BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: de Sousa Arantes Ferreira G, Claudio de Oliveira L, Roberto de Sousa Ulisses L, Luis Conde Watanabe A, Medeiros IN, Souto Siqueira Cardoso H, Creão da Costa Alves I, Martins de Almeida T, Viana de Lima L, Fontoura RP, Resende Sousa E Silva E, de Araújo PL. Combined Liver and Kidney Transplant in Acute Intermittent Porphyria: A Case Report. Am J Case Rep 2020;21:e927832. [PMID: 33203827 DOI: 10.12659/AJCR.927832] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Ventura P, Ricci A. Givosiran for the treatment of acute hepatic porphyria. Expert Review of Clinical Pharmacology. [DOI: 10.1080/17512433.2022.2075848] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
2 Ricci A, Guida CC, Manzini P, Cuoghi C, Ventura P. Kidney Involvement in Acute Hepatic Porphyrias: Pathophysiology and Diagnostic Implications. Diagnostics (Basel) 2021;11:2324. [PMID: 34943561 DOI: 10.3390/diagnostics11122324] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
3 Multiple drugs. Reactions Weekly 2021;1841:192-192. [DOI: 10.1007/s40278-021-90694-4] [Reference Citation Analysis]
4 Bustad HJ, Kallio JP, Vorland M, Fiorentino V, Sandberg S, Schmitt C, Aarsand AK, Martinez A. Acute Intermittent Porphyria: An Overview of Therapy Developments and Future Perspectives Focusing on Stabilisation of HMBS and Proteostasis Regulators. Int J Mol Sci 2021;22:E675. [PMID: 33445488 DOI: 10.3390/ijms22020675] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]